PAN-622, a fully human anti-HAAH monoclonal antibody
|
First Indication:
|
Treatment of hepatocellular carcinoma |
| Stage:
|
Late stage preclinical
|
PAN-622 - Toxin Conjugate
|
First Indication:
|
Treatment of carcinoma of the bile duct
|
|
Stage:
|
Preclinical
|
PAN-811
|
First Indication:
|
Treatment of Ischemic Stroke
|
|
Stage: |
Late stage preclinical
|
PAN-127
|
First Indication:
|
Treatment of Prostate Cancer
|
|
Stage: |
Preclinical
|
|
